MPN

Alef and Casa Systems Join Forces to Unlock Opportunity for Mobile Private Networks

Retrieved on: 
Monday, February 26, 2024
Mobile, GSMA, CPO, Mobile World Congress, Visibility, Policy, Wi-Fi, MPN, CASA, Mobile phone

NEW YORK and ANDOVER, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Alef , a leader in mobile connectivity solutions, and Casa Systems , provider of cloud-native network solutions serving communications services providers (CSPs) worldwide, have partnered to introduce a groundbreaking Mobile Private Network (MPN) solution.

Key Points: 
  • NEW YORK and ANDOVER, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Alef , a leader in mobile connectivity solutions, and Casa Systems , provider of cloud-native network solutions serving communications services providers (CSPs) worldwide, have partnered to introduce a groundbreaking Mobile Private Network (MPN) solution.
  • This innovative collaboration delivers CSPs a redefining MPN solution to drive scaled adoption throughout the enterprise sector.
  • The GSMA recently estimated that 5G MPNs represent a $109.4 billion revenue opportunity by 2030.
  • Visit us at Mobile World Congress 2024 in Barcelona, February 26-29 at Casa Systems Booth #2G11 in Hall 2.

Incyte Launches The Unseen Journey to Elevate the Hidden Impact of Myeloproliferative Neoplasms (MPNs) on Patients’ Lives through Generative AI

Retrieved on: 
Thursday, February 29, 2024
Technology, Medical Devices, Software, Audio, Video, Biotechnology, General Health, Pharmaceutical, Health, Oncology, Artificial Intelligence, Pancreatic serous cystadenoma, PV, Multimedia, AI, MF, Friends, Empathy, Education International, Bone marrow, Fatigue, Patient, Family, Headache, Ruxolitinib, MPN, Brain, Medical imaging

Incyte (Nasdaq: INCY) today announced the launch of The Unseen Journey, a program that brings to life the hidden emotional and physical toll of myeloproliferative neoplasms (MPNs), a group of rare, chronic and progressive blood cancers.

Key Points: 
  • Incyte (Nasdaq: INCY) today announced the launch of The Unseen Journey, a program that brings to life the hidden emotional and physical toll of myeloproliferative neoplasms (MPNs), a group of rare, chronic and progressive blood cancers.
  • View the full release here: https://www.businesswire.com/news/home/20240229692531/en/
    The Unseen Journey highlights the stories of people living with MPNs who were asked to describe their symptoms and how they impact their lives in their own words.
  • As each patient described their symptoms and experiences, generative AI tools transformed their words into images that visually depict the patient’s most burdensome symptoms.
  • It is important for MPN patients to track their symptoms on a regular basis to help inform conversations with their health care provider.

Miller Proctor Nickolas (“MPN”) (A Leading Provider of Industrial Heating Equipment) Announces Acquisition of Mobile Steam Boiler Rental Corporation (“MSBRC”) (A Leading Provider of Rental Boilers)

Retrieved on: 
Thursday, February 22, 2024
Hardware, Technology, Other Construction & Property, Residential Building & Real Estate, Other Manufacturing, Construction & Property, Other Transport, Engineering, Building Systems, Transport, Other Technology, Interior Design, Manufacturing, Acquisition, Fortune 500, Professional, Steam, Sale, University, System, NYC Metro, Heat, Hudson Street, MPN, Partnership, Property management

Miller Proctor Nickolas, Inc., (“MPN”) a leading heating solutions and services company, is pleased to announce the acquisition of Mobile Steam Boiler Rental Corp (“MSBRC”), a leading supplier of mobile rental boilers to the New York City Metro area.

Key Points: 
  • Miller Proctor Nickolas, Inc., (“MPN”) a leading heating solutions and services company, is pleased to announce the acquisition of Mobile Steam Boiler Rental Corp (“MSBRC”), a leading supplier of mobile rental boilers to the New York City Metro area.
  • Quote from Mobile Steam Boiler Rental Corporation’s President, Jeff Moskowitz
    "MPN has always been a top supplier to MSBRC.
  • About of Mobile Steam Boiler Rental Corp:
    Since 1969, Mobile Steam Boiler Rental Corp has been dedicated to helping our customers reduce the impact of boiler downtime for their tenants or industrial applications.
  • For more information, follow MPN on LinkedIn and please contact:
    2 Hudson Street Sleepy Hollow, NY 10591
    Mobile Steam Boiler Rental Corp Office:

Clinical Review of Pegylated Interferons Suggests Formulation and Mechanism of Action May Improve Outcomes for MPN Patients

Retrieved on: 
Wednesday, February 21, 2024
Science, Biotechnology, Research, Pharmaceutical, Oncology, General Health, Health, Clinical Trials, Myeloproliferative neoplasm, PV, University of Alabama, PMF, News, Treatment, Polycythemia, Manuscript, Interferon, Safety, University, Contraindication, Primary myelofibrosis, Associate, Patient, MPN, Pharmaceutical industry

The manuscript, "Interferons in the Treatment of Myeloproliferative Neoplasms” was co-authored by 12 renowned myeloproliferative neoplasm (MPN) specialists and published in Therapeutic Advances in Hematology .

Key Points: 
  • The manuscript, "Interferons in the Treatment of Myeloproliferative Neoplasms” was co-authored by 12 renowned myeloproliferative neoplasm (MPN) specialists and published in Therapeutic Advances in Hematology .
  • Writing and editorial support were funded by PharmaEssentia, however authors retained full editorial control and provided final approval on all content.
  • “Interferons are immune modulators that have been used to treat MPNs for more than 35 years.
  • “This review will continue to help the greater medical community better understand the potential of interferons, as well as potential dosing regimens and combination therapies for patients,” said Albert Qin, M.D., Ph.D., Chief Medical Officer, PharmaEssentia.

Ryvu Therapeutics to Present Preclinical Data on RVU120 and Synthetic Lethality Programs at the 2024 AACR Annual Meeting

Retrieved on: 
Wednesday, March 6, 2024
WBC, WRN, Lung cancer, RNA, Malignancy, Microsatellite instability, Proteome, Intellectual property, MMR, MPN, Glioblastoma, Neoplasm, Splenomegaly, DMPK, Phosphorylation, HDAC, STAT5, RNA-Seq, WES, Standard of care, Therapy, RecQ helicase, Phenotype, Ruxolitinib, DNA, DNA repair, Pancreatic serous cystadenoma, CDKN2A, Cancer, CRC, PIM, Arginine, MTA, Abstract, PDC, MTAP, Colorectal cancer, CRISPR, PV, MF, MSI-H, Cell, JAK, DNA mismatch repair, Medicine, Patient, Gene, PRMT5, Haematopoiesis, Mesothelioma, Pharmaceutical industry

Ryvu's partner Menarini to present data on MEN1703 (SEL24), demonstrating promising anti-tumor activity in preclinical models of myelofibrosis both as a single agent and combined with ruxolitinib.

Key Points: 
  • Ryvu's partner Menarini to present data on MEN1703 (SEL24), demonstrating promising anti-tumor activity in preclinical models of myelofibrosis both as a single agent and combined with ruxolitinib.
  • "We are excited to present our latest preclinical data at the AACR Annual Meeting, showcasing our significant progress in advancing novel small molecule therapies for oncology.
  • This year, we will present data from our most advanced preclinical project on MTA-cooperative PRMT5 inhibitors, the lead program within Ryvu's synthetic lethality pipeline.
  • Ryvu has developed potentially best-in-class MTA-cooperative PRMT5 inhibitors showing favorable drug-like properties and effective PRMT5 inhibition dependent on MTA binding.

Q4 2023 with strong financial results and continued mobile postpaid growth. Financial guidance 2023 achieved.

Retrieved on: 
Friday, February 16, 2024
B2C, FMC, 3000 (number), BKW, Mobile, SIM, Investment, Marketing, Swiss International Air Lines, Internet of things, Growth, CHF, Adjustment, FCF, Yoy, Migros, SME, Consumer, OPEX, Swype, TCS, MPN, Internet, Beauty salon

Q4 2023 with strong financial results and continued mobile postpaid growth.

Key Points: 
  • Q4 2023 with strong financial results and continued mobile postpaid growth.
  • Sunrise closed the year with a strong Q4 2023 driven by a return to revenue and Adjusted EBITDA growth and thereby reached all financial targets set for 2023.
  • Fixed-mobile convergence (FMC) continued to grow in 2023: as of 31 December 2023, 58.1% of fixed broadband customers also used a mobile postpaid offer (+0.7% YoY).
  • Adjusted EBITDA less P&E additions2)4) increased +55.4% YoY in Q4 2023 on a rebased basis and reached CHF 96.0 million.

MPN Boilers Partners with DP Pumps-USA for Stainless Steel Multi-Stage Pumps

Retrieved on: 
Thursday, February 1, 2024
HVAC, Other Construction & Property, Manufacturing, Construction & Property, Other Manufacturing, Steel, Hudson Street, MPN, DP, NPSH, Heat, Environmental remediation

This announcement provides an alternative solution for customers that rely on vertical or horizontal, multi-stage, high pressure pumping solutions.

Key Points: 
  • This announcement provides an alternative solution for customers that rely on vertical or horizontal, multi-stage, high pressure pumping solutions.
  • The DP Pump line of products is ideally suited for any replacement boiler feedwater pump application within any type of steam system.
  • DP Pumps are designed to be “drop-in” replacements for typical manufacturers including Grundfos and Goulds.
  • MPN is a 100% Employee-Owned company that has been providing heating solutions and services to New York for over 50 years.

CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program

Retrieved on: 
Saturday, December 9, 2023
Cancer research, Community, Survivor, MF, Caregiver, Research, Hope, Silver, CRTF, Trial of the century, MD Anderson Cancer Center, Oncology, Heart, Cancer, Ruxolitinib, Motivation, Richmond University Medical Center, MPN, CURE, Hematology, RN, Patient, Organization, University, Medicine, Nursing

CRANBURY, N.J., Dec. 08, 2023 (GLOBE NEWSWIRE) -- CURE Media Group, the industry-leading multimedia platform devoted to providing cancer updates and research to more than 1 million patients, survivors and caregivers, today announced the recipients of the 2023 MPN Heroes® Recognition Program.

Key Points: 
  • CRANBURY, N.J., Dec. 08, 2023 (GLOBE NEWSWIRE) -- CURE Media Group, the industry-leading multimedia platform devoted to providing cancer updates and research to more than 1 million patients, survivors and caregivers, today announced the recipients of the 2023 MPN Heroes® Recognition Program.
  • Marilyn Kay Edwards is an MPN Hero for her outreach as an MPN peer with CHAMPN, the Community Voice Champion Program.
  • Marina Kremyanskaya, M.D., Ph.D., is an MPN Hero because of her extraordinary impact as an educator, physician and leader in MPN research.
  • Incyte partners with CURE Media Group to support the program, with CURE hosting the annual MPN Heroes recognition ceremony.

Hôpital Saint-Louis Implements SOPHiA DDM™ Platform to Further Research of Myeloid Disorders

Retrieved on: 
Thursday, December 21, 2023
Doctor of Pharmacy, NGS, Medicine, Molecular diagnostics, Research, Hospital, Cell biology, Sophia Genetics, GENETICS, MPN, Artificial intelligence, Patient, Platform, Myeloproliferative neoplasm, Pharmaceutical industry

BOSTON and ROLLE, Switzerland, Dec. 21, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Hôpital Saint-Louis, located in Paris, has implemented the SOPHiA DDM™ Platform to help advance its research of Myeloid Disorders and continue expanding the use of precision medicine for those in the area. This latest implementation is an expansion of its existing work with SOPHiA GENETICS.

Key Points: 
  • The implementation of the SOPHiA DDM™ Platform will help the Cellular Biology Department expedite its research and increase its ability to provide data-driven care to patients with MPN.
  • "The SOPHiA DDM™ Platform has been an essential tool to support us in streamlining our bioinformatics workflows, expediting our research, and making data-driven decisions for our patient population."
  • The SOPHiA DDM™ Platform is a NGS-based application that uses artificial intelligence (AI) to efficiently analyze and interpret raw NGS data for researchers.
  • For more information on SOPHiA GENETICS, visit SOPHiAGENETICS.COM , or connect on X , LinkedIn , Facebook , and Instagram .

CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition program

Retrieved on: 
Thursday, November 16, 2023
Adolescence, Potential, Research, Climate change, His Excellency (1944 film), Government, Patient, CURE, Academy Awards, MPN, Movement, Caregiver, Greenpeace USA, Pancreatic serous cystadenoma, Cancer, Partnership, Survivor, Society, AFI Life Achievement Award, Environment, Film industry

CRANBURY, N.J., Nov. 16, 2023 (GLOBE NEWSWIRE) -- CURE Media Group, the industry-leading multimedia platform devoted to providing cancer updates and research to more than 1 million patients, survivors and caregivers, today announced that Academy Award-winning actor, author, producer, political activist and fitness guru Jane Fonda is the keynote speaker for the 2023 MPN Heroes recognition program. The event will be held December 8 in conjunction with the American Society of Hematology Annual Meeting and Exposition in San Diego, California.

Key Points: 
  • CRANBURY, N.J., Nov. 16, 2023 (GLOBE NEWSWIRE) -- CURE Media Group, the industry-leading multimedia platform devoted to providing cancer updates and research to more than 1 million patients, survivors and caregivers, today announced that Academy Award-winning actor, author, producer, political activist and fitness guru Jane Fonda is the keynote speaker for the 2023 MPN Heroes recognition program.
  • Academy Award-winning actor, author, producer, political activist and fitness guru Jane Fonda, is the keynote speaker for CURE Media Group's 2023 MPN Heroes recognition program.
  • “We are truly honored to have Jane Fonda as our keynote speaker for the 2023 MPN Heroes recognition program,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences®, the parent company of CURE.
  • For more information on the 2023 MPN Heroes recognition program, click here .